Veradigm and PRA Health Sciences Partner to Create the Industry’s Leading EHR-Based Clinical Research Network

Veradigm®, a healthcare data and technology company and business unit of Allscripts Healthcare Solutions, and PRA Health Sciences Inc., a global contract research organization, announced the creation of the industry’s leading electronic healthcare records-based clinical research network that reaches more than 25,000 physicians and 40 million patients across the United States.

Using Veradigm’s StudySource platform, which extends existing EHR systems to include clinical research, alongside PRA’s proprietary eSource technology and clinical research expertise, this network will enable any of our physicians to offer clinical research as a care option (CRACCO) to their patients – driving efficiencies across the trial process and increasing the accessibility and diversity in clinical trials.

“The current approach to clinical trials is disconnected from healthcare delivery and requires manual data collection, which creates barriers for physicians and patients to participate. Today, less than one percent of the US population participates in clinical research, despite patients’ willingness to participate if asked,” said Stephanie Reisinger, Vice President and General Manager of Veradigm’s Life Sciences Research business

Data management and monitoring are two of the most lengthy and costly stages of a clinical trial, yet much of this data already exists in EHR systems. With PRA’s proprietary eSource technology, data transfers can be automated from Veradigm’s EHRs to an electronic data capture system. This approach enables clients to speed drug development by decreasing the effort and time at this stage and reducing transcription errors.

Technologies supporting both Veradigm and PRA Health Sciences are securely hosted in the Microsoft Azure.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!

  • <<
  • >>

Join the Discussion